Rachele Prevostini
Papers
1
Total Citations
7
H-Index
1
About
Rachele Prevostini is at the forefront of cardiac electrophysiology, pioneering the integration of automated patch-clamp technology with induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) to unravel the mechanisms of Brugada syndrome. Her landmark 2023 study, which has already garnered 7 citations, established a high-throughput platform capable of characterizing ion channel dysfunction in patient-specific cardiomyocytes—a breakthrough that bridges the gap between genetic mutations and clinical arrhythmia risk. By demonstrating how automated patch-clamping can reliably capture the subtle electrophysiological signatures of Brugada syndrome, Prevostini’s work offers a scalable, reproducible alternative to traditional manual techniques. This synergistic approach not only accelerates the functional validation of disease-associated variants but also provides a powerful tool for drug screening and personalized risk stratification. Her contributions are shaping a new paradigm in precision cardiology, where stem cell models and automated electrophysiology converge to translate bench discoveries into actionable clinical insights for sudden cardiac death prevention.
Research Focus
Key Achievements
Top Papers
- 1